Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.58 USD | +5.99% | +3.87% | +110.29% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 1.89B |
---|---|---|---|---|---|
Net income 2024 * | -241M | Net income 2025 * | -308M | EV / Sales 2024 * | - |
Net cash position 2024 * | 162M | Net cash position 2025 * | 285M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-7.56
x | P/E ratio 2025 * |
-6.86
x | Employees | 328 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.84% |
Latest transcript on Sana Biotechnology, Inc.
1 day | +5.99% | ||
1 week | +3.87% | ||
Current month | -14.20% | ||
1 month | -6.23% | ||
3 months | +61.28% | ||
6 months | +187.92% | ||
Current year | +110.29% |
Managers | Title | Age | Since |
---|---|---|---|
Steven Harr
FOU | Founder | 53 | 18-07-12 |
Nathan Hardy
DFI | Director of Finance/CFO | 48 | 18-08-31 |
Gary Meininger
CTO | Chief Tech/Sci/R&D Officer | - | 23-04-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 69 | 20-04-30 | |
Patrick Yang
BRD | Director/Board Member | 75 | 18-09-30 |
Robert Nelsen
FOU | Founder | 60 | 18-07-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.07% | 2 M€ | -.--% | ||
0.05% | 0 M€ | 0.00% | - | |
0.03% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 8.58 | +6.06% | 1,221,006 |
24-04-23 | 8.09 | +2.02% | 1,688,156 |
24-04-22 | 7.93 | +4.20% | 2,126,514 |
24-04-19 | 7.61 | -1.55% | 3,379,017 |
24-04-18 | 7.73 | -6.42% | 1,882,326 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+110.29% | 1.89B | |
+4.09% | 43.84B | |
+47.07% | 41.25B | |
+9.45% | 41.68B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+29.70% | 12.29B | |
+1.28% | 12.29B | |
+7.78% | 11.15B |
- Stock Market
- Equities
- SANA Stock